Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial

Ayahuasca is a classic hallucinogen with anxiolytic and antidepressive properties. Anecdotal evidence also suggests that it improves performance (eg, singing, speech). This controlled trial assessed the effects of ayahuasca on speech performance and anxiety in individuals with social anxiety disorde...

Full description

Saved in:
Bibliographic Details
Published inJournal of clinical psychopharmacology Vol. 41; no. 5; p. 540
Main Authors Dos Santos, Rafael G, Osório, Flávia de Lima, Rocha, Juliana Mendes, Rossi, Giordano Novak, Bouso, José Carlos, Rodrigues, Lucas S, de Oliveira Silveira, Gabriela, Yonamine, Mauricio, Hallak, Jaime E Cecílio
Format Journal Article
LanguageEnglish
Published United States 01.09.2021
Subjects
Online AccessGet more information
ISSN1533-712X
DOI10.1097/JCP.0000000000001428

Cover

Abstract Ayahuasca is a classic hallucinogen with anxiolytic and antidepressive properties. Anecdotal evidence also suggests that it improves performance (eg, singing, speech). This controlled trial assessed the effects of ayahuasca on speech performance and anxiety in individuals with social anxiety disorder. Seventeen volunteers with social anxiety disorder participated in a pilot, proof-of-concept, randomized, parallel-group trial. Self-perception of performance during a public-speaking test was assessed with the Self-statements During Public Speaking Scale primary outcome). Secondary outcomes included anxiety/subjective effects (Visual Analog Mood Scale; Bodily Symptoms Scale), recognition of emotions in facial expressions (REFE), tolerability measures (cardiovascular measures, self-reports), and brain-derived neurotrophic factor plasma levels. Effects on anxiety and REFE were assessed again 7, 14, and 21 days postdrug. Compared with placebo, ayahuasca significantly improved self-perception of speech performance (Self-statements During Public Speaking Scale) and increased somatic symptoms (Bodily Symptoms Scale). There was also a significant time × group interaction in the cognitive deterioration Visual Analog Mood Scale factor and a significant effect of time in the REFE task, especially in reaction time. Other measures were not significantly modified. Ayahuasca was well tolerated, producing mainly nausea, gastrointestinal discomfort, and vomiting. Ayahuasca improved self-perception of speech performance in socially anxious individuals. These effects occurred independent of task-related anxiety and REFE, suggesting that ayahuasca could specifically improve the cognitive aspect of speech performance. Further studies should try to unveil the mechanisms involved in the effects of ayahuasca and to better understand its effects on anxiety.
AbstractList Ayahuasca is a classic hallucinogen with anxiolytic and antidepressive properties. Anecdotal evidence also suggests that it improves performance (eg, singing, speech). This controlled trial assessed the effects of ayahuasca on speech performance and anxiety in individuals with social anxiety disorder. Seventeen volunteers with social anxiety disorder participated in a pilot, proof-of-concept, randomized, parallel-group trial. Self-perception of performance during a public-speaking test was assessed with the Self-statements During Public Speaking Scale primary outcome). Secondary outcomes included anxiety/subjective effects (Visual Analog Mood Scale; Bodily Symptoms Scale), recognition of emotions in facial expressions (REFE), tolerability measures (cardiovascular measures, self-reports), and brain-derived neurotrophic factor plasma levels. Effects on anxiety and REFE were assessed again 7, 14, and 21 days postdrug. Compared with placebo, ayahuasca significantly improved self-perception of speech performance (Self-statements During Public Speaking Scale) and increased somatic symptoms (Bodily Symptoms Scale). There was also a significant time × group interaction in the cognitive deterioration Visual Analog Mood Scale factor and a significant effect of time in the REFE task, especially in reaction time. Other measures were not significantly modified. Ayahuasca was well tolerated, producing mainly nausea, gastrointestinal discomfort, and vomiting. Ayahuasca improved self-perception of speech performance in socially anxious individuals. These effects occurred independent of task-related anxiety and REFE, suggesting that ayahuasca could specifically improve the cognitive aspect of speech performance. Further studies should try to unveil the mechanisms involved in the effects of ayahuasca and to better understand its effects on anxiety.
Author Osório, Flávia de Lima
Dos Santos, Rafael G
Rodrigues, Lucas S
de Oliveira Silveira, Gabriela
Rossi, Giordano Novak
Bouso, José Carlos
Hallak, Jaime E Cecílio
Rocha, Juliana Mendes
Yonamine, Mauricio
Author_xml – sequence: 1
  givenname: Rafael G
  surname: Dos Santos
  fullname: Dos Santos, Rafael G
– sequence: 2
  givenname: Flávia de Lima
  surname: Osório
  fullname: Osório, Flávia de Lima
– sequence: 3
  givenname: Juliana Mendes
  surname: Rocha
  fullname: Rocha, Juliana Mendes
  organization: From the Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto
– sequence: 4
  givenname: Giordano Novak
  surname: Rossi
  fullname: Rossi, Giordano Novak
  organization: From the Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto
– sequence: 5
  givenname: José Carlos
  surname: Bouso
  fullname: Bouso, José Carlos
– sequence: 6
  givenname: Lucas S
  surname: Rodrigues
  fullname: Rodrigues, Lucas S
  organization: From the Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto
– sequence: 7
  givenname: Gabriela
  surname: de Oliveira Silveira
  fullname: de Oliveira Silveira, Gabriela
  organization: School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil
– sequence: 8
  givenname: Mauricio
  surname: Yonamine
  fullname: Yonamine, Mauricio
  organization: School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil
– sequence: 9
  givenname: Jaime E Cecílio
  surname: Hallak
  fullname: Hallak, Jaime E Cecílio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34166299$$D View this record in MEDLINE/PubMed
BookMark eNpNkOtKwzAcxYMo7qJvIJIHWGeT9Ba_lXqbDCx2ot9GmvzDMtqmpJ04H8cntUMFDwcOnAO_D2eCjhvbAEIXxJ8Tn8dXj1k-9_-JBDQ5QmMSMubFhL6N0KTrtoc-puEpGrGARBHlfIy-0r3Y7EQnBV7UrbPv0OECKu214CS0vbENthoXLYDc4Byctq4WjQRsGlzsyi3IvsOvpt_gwkojKpw2Hwb6Pb4xnXUK3DVOcW4q289w7qzV3uDMNgf4DD-LRtnafIIa1kpIKO1h7J2tKlB45QbiGTrRourg_Den6OXudpU9eMun-0WWLj3JQhp5nNGEsZiWSgY84TIM4gR0RBWJOQ15qSkMfKJpCZGv_ECGOogUZZz5ImTDHVN0-cNtd2UNat06Uwu3X_-dRb8BNQ1uOA
CitedBy_id crossref_primary_10_1016_j_ijchp_2022_100349
crossref_primary_10_3389_fpsyt_2024_1431389
crossref_primary_10_1016_j_psychres_2024_115880
crossref_primary_10_1177_02698811221116926
crossref_primary_10_3390_biom12111618
crossref_primary_10_1007_s41603_023_00203_y
crossref_primary_10_1016_j_jep_2023_117430
crossref_primary_10_3390_molecules27082520
crossref_primary_10_1016_j_psychres_2024_115886
crossref_primary_10_1080_02791072_2024_2424288
crossref_primary_10_1080_14740338_2022_2054988
crossref_primary_10_1016_j_pnpbp_2023_110738
crossref_primary_10_1093_schbul_sbad094
crossref_primary_10_1097_JCP_0000000000001941
crossref_primary_10_1097_JCP_0000000000001888
crossref_primary_10_1016_j_neubiorev_2024_105570
crossref_primary_10_1080_14740338_2022_2063274
crossref_primary_10_1016_j_neuropharm_2025_110413
crossref_primary_10_1038_s41380_024_02800_5
crossref_primary_10_61373_pp024i_0037
crossref_primary_10_1080_02791072_2022_2077155
crossref_primary_10_2174_1570159X20666220425133824
crossref_primary_10_3389_fpsyt_2024_1485337
crossref_primary_10_1016_j_pnpbp_2025_111279
crossref_primary_10_7759_cureus_55574
crossref_primary_10_1007_s40263_024_01101_3
crossref_primary_10_1177_02698811241273772
crossref_primary_10_1017_S109285292400213X
crossref_primary_10_1080_14737175_2024_2445016
crossref_primary_10_1177_20451253231172254
crossref_primary_10_1089_psymed_2023_0007
crossref_primary_10_1111_nyas_15082
crossref_primary_10_1002_pcn5_146
crossref_primary_10_1016_j_jpsychires_2025_03_022
crossref_primary_10_1089_psymed_2023_0028
crossref_primary_10_1177_02698811231155117
crossref_primary_10_1097_JCP_0000000000001536
crossref_primary_10_1097_JCP_0000000000001872
crossref_primary_10_1016_j_euroneuro_2022_10_008
crossref_primary_10_1007_s00213_024_06598_6
crossref_primary_10_1097_JCP_0000000000001691
ContentType Journal Article
Copyright Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Copyright_xml – notice: Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1097/JCP.0000000000001428
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1533-712X
ExternalDocumentID 34166299
Genre Randomized Controlled Trial
Journal Article
GroupedDBID ---
.-D
.3C
.GJ
.Z2
01R
0R~
1CY
1J1
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
8L-
AAAAV
AAAXR
AAGIX
AAHPQ
AAIQE
AAMOA
AAMTA
AAQKA
AAQQT
AARTV
AASCR
AASOK
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABIVO
ABJNI
ABVCZ
ABXVJ
ABZAD
ABZZY
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACIJW
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEETU
AENEX
AFBFQ
AFDTB
AFFNX
AFUWQ
AGINI
AHOMT
AHQNM
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BOYCO
BQLVK
BS7
BYPQX
C45
CGR
CS3
CUY
CVF
DIWNM
DU5
DUNZO
E.X
EBS
ECM
EEVPB
EIF
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
H0~
HLJTE
HZ~
H~9
IKREB
IKYAY
IN~
JF9
JG8
JK3
JK8
K8S
KD2
KMI
L-C
N4W
N9A
NEJ
NPM
N~7
N~B
N~M
O9-
OAG
OAH
OCUKA
ODA
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OMH
OPC
OPUJH
OPX
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
R58
RLZ
S4R
S4S
T8P
TEORI
TSPGW
V2I
VVN
W3M
WOQ
WOW
X3V
X3W
XXN
XYM
YFH
YOC
ZFV
ZGI
ZXP
ZY1
ZZMQN
ID FETCH-LOGICAL-c3526-93283372bdc4989c5478ef62d179259bf2eace1f2be60d04c5f46d23930a53662
IngestDate Thu Apr 03 06:49:09 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c3526-93283372bdc4989c5478ef62d179259bf2eace1f2be60d04c5f46d23930a53662
PMID 34166299
ParticipantIDs pubmed_primary_34166299
PublicationCentury 2000
PublicationDate 2021-09-01
PublicationDateYYYYMMDD 2021-09-01
PublicationDate_xml – month: 09
  year: 2021
  text: 2021-09-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of clinical psychopharmacology
PublicationTitleAlternate J Clin Psychopharmacol
PublicationYear 2021
SSID ssj0014725
Score 2.5187478
Snippet Ayahuasca is a classic hallucinogen with anxiolytic and antidepressive properties. Anecdotal evidence also suggests that it improves performance (eg, singing,...
SourceID pubmed
SourceType Index Database
StartPage 540
SubjectTerms Adult
Anti-Anxiety Agents - adverse effects
Anti-Anxiety Agents - therapeutic use
Banisteriopsis - adverse effects
Female
Humans
Male
Phobia, Social - drug therapy
Pilot Projects
Self Concept
Speech
Young Adult
Title Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial
URI https://www.ncbi.nlm.nih.gov/pubmed/34166299
Volume 41
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF41IFAviGd5aw6ol8Tg2OsXtxAoVQ_BqlLRW7W2d1WDa1ukrWh_Dr-UmV2_lLYIiCIr8lpWvPN5d2b2-2YZe5MoLxIZvt8i9LjFA8ezEof7FufKTlMnFIlhWyz83QO-d-gdbozuDFhLZ6fJ2_TyWl3J_1gVz6FdSSX7D5btboon8DfaF49oYTz-lY1nF-L4TKxSMTa5AbnCd79QVt2xVbQmpZYyPSaueycRyEsaMb5pJsdXysQ2Kt1Z-VNzONuanEa3HudFZci86GYrC79zI3bU9hFlVp3klyZpGlNWPqnoAmLAF-jOLqkjbvCBO12mEYPVfR3tLtP_scKHop2OTUpIKCGLfkOwLyta6f_g_sh1ynen0Av_0_NcjDNJ6q1u1tmvUrO2RYpwUQri82Y9gXIfnQVNbPic45OLshovqnPxfZgUcaYd6wvntHYgd61gqrdq70Z6U2KrQbQ3GLY9UzLqynRiyhTvzWNT5rL5UJG64eVoi_pEQwxdAt93zI5Pf25dK_LdNo3YKAhofllQ0qlZDKM3qFV9RsG76_7OJrvb3mItPtJ-0vI-u9cYF2YGrQ_Yhiwfsu3YWPZiAste8LeawDbEA5s_Yr86SEMLaViDNFQKDKRhAGnIS2ghDQRpMJCGBtLQQvo9zEADegLrcJ5AD2ZsvQJl0FB-zA52Pi3nu1azjYiV0uYPFkYooesGTpKlPAqjlCrYSeU7Gc5FGPwnykHnQ06Vk0jfzmyeeor7GZUGtIXnYp8-YbfKqpRPGfhOmGE8zjOOYbgtMDpSAuMTgUGIH3lh9Ixtmb4_qk2tmKPWKs9vbHnBNnsEv2S3FQ5O8hV6uqfJa42D33ChqHo
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ayahuasca+Improves+Self-perception+of+Speech+Performance+in+Subjects+With+Social+Anxiety+Disorder%3A+A+Pilot%2C+Proof-of-Concept%2C+Randomized%2C+Placebo-Controlled+Trial&rft.jtitle=Journal+of+clinical+psychopharmacology&rft.au=Dos+Santos%2C+Rafael+G&rft.au=Os%C3%B3rio%2C+Fl%C3%A1via+de+Lima&rft.au=Rocha%2C+Juliana+Mendes&rft.au=Rossi%2C+Giordano+Novak&rft.date=2021-09-01&rft.eissn=1533-712X&rft.volume=41&rft.issue=5&rft.spage=540&rft_id=info:doi/10.1097%2FJCP.0000000000001428&rft_id=info%3Apmid%2F34166299&rft_id=info%3Apmid%2F34166299&rft.externalDocID=34166299